(Translated by https://www.hiragana.jp/) KEGG DRUG: Recombinant adsorbed bivalent human papillomavirus-like particle vaccine (derived from Trichoplusia ni cells)
DRUG: Recombinant adsorbed bivalent human papillomavirus-like particle vaccine (derived from Trichoplusia ni cells)
Entry
D10212 Drug
Name
Recombinant adsorbed bivalent human papillomavirus-like particle vaccine (derived from Trichoplusia ni cells); Cervarix (TN)
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J07 VACCINES
J07B VIRAL VACCINES
J07BM Papillomavirus vaccines
J07BM02 Papillomavirus (human types 16, 18)
D10212 Recombinant adsorbed bivalent human papillomavirus-like particle vaccine (derived from Trichoplusia ni cells) <JP>
Therapeutic category of drugs in Japan [BR:br08301]
6 Agents against pathologic organisms and parasites
63 Biological preparations
631 Vaccines
6313 Viral vaccines
D10212 Recombinant adsorbed bivalent human papillomavirus-like particle vaccine (derived from Trichoplusia ni cells)
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D10212
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D10212